MillionMilesAway
Well-Known Member
Thanks for the response but I dont think it really answered my question. Why havent they banned the Pfizer vaccine if they have also encountered a similar ammount of blood clots in those patients.
I suppose the obvious question is "have they encountered that for Pfizer?"
It comes down to what is reported to them, and then collating the data and people involved to see if there is a case. That takes time to do.
It is unthinkable that a regulator would carry on allowing administration of something that is being reported for downsides. That would absolutely ruin trust in the regulator.